Nephrology Department, Peking University International Hospital, No. 1 Life Park Road, Life Science Park of Zhongguancun, Changping District, Beijing, 102206, P.R. China.
BMC Nephrol. 2024 Aug 26;25(1):273. doi: 10.1186/s12882-024-03714-8.
Refractory exit-site infections (ESIs) and tunnel infections (TIs) are challenging complications for patients undergoing peritoneal dialysis (PD). This study compared the outcomes of surgical intervention, notably the cuff-shaving (CS) procedure coupled with negative-pressure wound therapy (NPWT), and conservative management strategies for patients with refractory ESI and TI.
We retrospectively reviewed patients who underwent PD at our center, focusing on the incidence and management of ESI and TI. We evaluated and compared treatment outcomes, including ESI scores, frequency of ESI and/or TI, identification of causative microorganisms, and duration of catheter survival or time until removal.
We identified 97 episodes of catheter-related ESI and/or TI across 71 patients with an incidence rate of 0.15 episodes per patient-year. Of the 23 patients with refractory ESI and/or TI, surgical intervention was performed in 8, while 15 chose conservative management. In the one-month follow-up, patients who underwent CS combined with NPWT showed no complications such as leakage, and their local symptoms resolved completely. The mean PD catheter survival time was significantly longer in the surgical group (29.38 ± 7.25 months) than in the conservative group (7.86 ± 2.13 months). Surgical intervention demonstrated a significantly higher therapeutic efficacy and extended catheter survival.
The combination of CS and NPWT as a surgical approach is crucial for eradicating infectious foci and significantly improving the longevity of PD catheter function. This integrated surgical strategy offers a promising solution for the management of refractory ESI and TI in patients undergoing PD.
难治性出口部位感染(ESI)和隧道感染(TI)是接受腹膜透析(PD)患者面临的挑战性并发症。本研究比较了手术干预(尤其是套袖切除(CS)联合负压伤口治疗(NPWT))和保守管理策略对难治性 ESI 和 TI 患者的治疗结果。
我们回顾性分析了在我们中心接受 PD 的患者,重点关注 ESI 和 TI 的发生率和管理。我们评估和比较了治疗结果,包括 ESI 评分、ESI 和/或 TI 的发生频率、致病微生物的鉴定以及导管存活时间或去除时间。
我们在 71 名患者中发现了 97 例与导管相关的 ESI 和/或 TI,发生率为 0.15 例/患者年。在 23 例难治性 ESI 和/或 TI 患者中,8 例接受了手术干预,15 例选择了保守治疗。在一个月的随访中,接受 CS 联合 NPWT 的患者没有出现渗漏等并发症,其局部症状完全缓解。手术组的 PD 导管平均存活时间明显长于保守组(29.38±7.25 个月 vs. 7.86±2.13 个月)。手术干预具有更高的治疗效果和更长的导管存活时间。
CS 和 NPWT 的联合作为一种手术方法对于消除感染灶至关重要,并且显著提高 PD 导管功能的寿命。这种综合手术策略为 PD 患者难治性 ESI 和 TI 的管理提供了一种有前景的解决方案。